Pluvicto™ now publicly funded for patients with progressive PSMA-positive metastatic castration-resistant prostate cancer Decision underscores the urgent need for innovative treatments for individuals with advanced prostate cancer who have exhausted… Read More
Expansion strengthens diagnostic capabilities, enhances operational efficiency and supports broader patient access across the Northeast BURLINGTON, NC – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services,… Read More
OTTAWA, ON – Innovative Medicines Canada (IMC) is pleased to welcome Patrick Hupé, M.Sc., MBA, as Vice President of Government and Stakeholder Relations. Patrick brings over 25 years of experience… Read More
INM-089 IVT formulation selected for continued development Demonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a significant safety margin… Read More
VANCOUVER, BC – Life Sciences BC (LSBC), a non-government, not-for-profit organization that works to advance British Columbia’s (B.C.’s) life sciences sector, announces approval to receive over $1.1 million over three… Read More
